CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.72−0.02 (-2.35%)
Close on Oct 19, 2026
- Market cap
- $2.68M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
5.7%
0M of 7M shares
Institutional holders
13
5 new, 3 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Timothy Warbington | 1,040,762 | 13.70% | 13D (active) | Sep 24, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CELZ | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 135,170 | 2.05% | $196.00K | New | 0.00% |
| Anson Funds Management LP | 105,549 | 1.60% | $153.05K | New | 0.01% |
| Armistice Capital, LLC | 42,000 | 0.64% | $60.90K | New | 0.00% |
| XTX Topco Ltd | 26,559 | 0.40% | $38.51K | +12,299 | 0.00% |
| Geode Capital Management, LLC | 25,799 | 0.39% | $37.42K | −12,491 | 0.00% |
| Vanguard Capital Management LLC | 20,350 | 0.31% | $29.51K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 5,518 | 0.08% | $8.00K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 4,853 | 0.07% | $7.04K | +2,761 | 0.00% |
| Global Retirement Partners, LLC | 4,118 | 0.06% | $5.97K | New | 0.00% |
| UBS Group AG | 2,061 | 0.03% | $2.99K | +2,060 | 0.00% |
| Morgan Stanley | 514 | 0.01% | $745 | −20 | 0.00% |
| Barclays PLC | 54 | 0.00% | $78 | New | 0.00% |
| SBI Securities Co., Ltd. | 43 | 0.00% | $62 | +42 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 13 | 0M | 5.7% | 5 / 4 | 2 / 3 | 0M | 0M |
| Q1 2026 | 11 | 0M | 1.5% | 6 / 2 | 2 / 6 | 0M | 0M |
| Q4 2025 | 14 | 0M | 2.0% | 5 / 3 | 1 / 3 | 0M | 0M |
| Q3 2025 | 12 | 0M | 1.1% | 4 / 3 | 1 / 4 | 0M | 0M |
| Q2 2025 | 12 | 0M | 1.1% | 4 / 2 | 2 / 3 | 0M | 0M |
| Q1 2025 | 11 | 0M | 3.1% | 3 / 4 | 0 / 0 | 0M | 0M |
| Q4 2024 | 8 | 0M | 0.5% | 1 / 2 | 2 / 3 | 0M | 0M |
| Q3 2024 | 10 | 0M | 1.0% | 1 / 1 | 3 / 0 | 0M | 0M |
| Q2 2024 | 9 | 0M | 1.1% | 1 / 5 | 3 / 5 | 0M | 0M |
| Q1 2024 | 13 | 0M | 1.6% | 7 / 4 | 0 / 2 | 0M | 0M |
| Q4 2023 | 8 | 0M | 0.3% | 1 / 1 | 4 / 1 | 0M | 0M |
| Q3 2023 | 8 | 0M | 0.3% | 0 / 3 | 2 / 1 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CELZ | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 27,549 | 0.42% | $61.99K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 20,350 | 0.31% | $29.51K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 3,969 | 0.06% | $8.93K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 1,551 | 0.02% | $3.49K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Timothy Warbington | President & CEO, Director, 10% owner | 1,047,113 | 15.88% | Sep 25, 2026 |
| Acquisition Corp. Creative | Director | – | – | Sep 25, 2026 |
| Michael H. Finger | Director | 351 | 0.01% | Feb 20, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Timothy Warbington President & CEO, Director, 10% owner | Sep 24, 2026 | Award | +1,000,000 | – | – | 1,034,904 |
| Michael H. Finger Director | Feb 19, 2025 | Sale | −750 | $5.75 | $4.31K | 351 |
| Michael H. Finger Director | Feb 18, 2025 | Sale | −750 | $5.00 | $3.75K | 1,101 |
| Timothy Warbington President & CEO, Director | Jun 28, 2023 | Buy | +200 | $4.36 | $872 | 12,209 |
| Timothy Warbington President & CEO, Director | Jun 27, 2023 | Buy | +300 | $4.45 | $1.34K | 11,809 |
| Timothy Warbington President & CEO, Director | Jun 27, 2023 | Buy | +300 | $4.40 | $1.32K | 11,509 |
| Timothy Warbington President & CEO, Director | Jun 27, 2023 | Buy | +200 | $4.48 | $896 | 12,009 |
| Timothy Warbington President & CEO, Director | Nov 22, 2022 | Buy | +200 | $0.38 | $76 | 112,087 |
| Timothy Warbington President & CEO, Director | Nov 22, 2022 | Buy | +9,800 | $0.39 | $3.82K | 111,887 |
| Timothy Warbington President & CEO, Director | Nov 21, 2022 | Buy | +5,000 | $0.39 | $1.95K | 102,087 |
| Timothy Warbington President & CEO, Director | Nov 21, 2022 | Buy | +10,000 | $0.40 | $4.00K | 97,087 |
| Michael H. Finger Director | Sep 27, 2022 | Buy | +2,000 | $0.50 | $1.00K | 18,502 |
| Timothy Warbington President & CEO, Director | Sep 27, 2022 | Buy | +20,000 | $0.50 | $10.00K | 87,087 |
| Timothy Warbington President & CEO, Director | Sep 22, 2022 | Buy | +12,000 | $0.54 | $6.48K | 67,087 |
| Timothy Warbington President & CEO, Director | Sep 21, 2022 | Buy | +4,500 | $0.64 | $2.88K | 34,587 |
| Timothy Warbington President & CEO, Director | Sep 21, 2022 | Buy | +5,000 | $0.61 | $3.05K | 30,087 |
| Timothy Warbington President & CEO, Director | Sep 21, 2022 | Buy | +20,000 | $0.61 | $12.20K | 55,087 |
| Timothy Warbington President & CEO, Director | Sep 21, 2022 | Buy | +500 | $0.63 | $315 | 35,087 |
| Michael H. Finger Director | Jun 14, 2022 | Buy | +10,000 | $0.70 | $7.00K | 16,502 |
| Timothy Warbington President & CEO, Director | Jun 6, 2022 | Buy | +2,000 | $0.92 | $1.84K | 2,087 |
| Timothy Warbington President & CEO, Director | Jun 6, 2022 | Buy | +8,000 | $0.92 | $7.36K | 10,087 |
| Timothy Warbington President & CEO, Director | Jun 6, 2022 | Buy | +15,000 | $0.91 | $13.65K | 25,087 |
| Michael H. Finger Director | May 20, 2022 | Buy | +6,500 | $1.50 | $9.75K | 6,502 |
| Thomas Ichim Director | Jul 22, 2021 | Sale | −1,450,000 | $0.03 | $43.50K | 4,529,522 |
| Thomas Ichim Director | Jul 21, 2021 | Sale | −1,500,000 | $0.03 | $45.00K | 5,979,522 |
| Thomas Ichim Director | Jul 20, 2021 | Sale | −1,400,000 | $0.03 | $42.00K | 7,479,522 |
| Thomas Ichim Director | Jun 28, 2021 | Option exercise | +10,000,000 | – | – | 10,000,000 |
| Thomas Ichim Director | Jun 28, 2021 | Tax withholding | −1,120,448 | $0.04 | $44.82K | 8,879,552 |
| Medical Health Inc. Creative 10% owner | Jan 8, 2021 | Other | +44,642,857 | – | – | 113,474,233 |
| Timothy Warbington President & CEO, Director, 10% owner | Jan 8, 2021 | Other | +44,642,857 | – | – | 113,474,233 |
| Timothy Warbington President & CEO, Director, 10% owner | Sep 30, 2020 | Other | +42,328,042 | – | – | 68,831,376 |
| Medical Health Inc. Creative 10% owner | Sep 30, 2020 | Other | +42,328,042 | – | – | 68,831,376 |
| Medical Health Inc. Creative 10% owner | Jun 3, 2020 | Other | +19,736,842 | – | – | 26,503,334 |
| Timothy Warbington President & CEO, Director, 10% owner | Jun 3, 2020 | Other | +19,736,842 | – | – | 26,503,334 |
| Timothy Warbington President & CEO, Director, 10% owner | Feb 17, 2020 | Other | +2,250,000 | $0.02 | $45.00K | 6,766,492 |
| Medical Health Inc. Creative 10% owner | Feb 17, 2020 | Other | +2,250,000 | $0.02 | $45.00K | 6,766,492 |
| Timothy Warbington President & CEO, Director, 10% owner | Dec 13, 2019 | Other | +500,000,000 | – | – | 677,473,616 |
| Medical Health Inc. Creative 10% owner | Dec 13, 2019 | Other | +500,000,000 | – | – | 677,473,616 |
| Timothy Warbington President & CEO, Director, 10% owner | Nov 5, 2019 | Other | +100,000,000 | – | – | 177,473,616 |
| Medical Health Inc. Creative 10% owner | Nov 5, 2019 | Other | +100,000,000 | – | – | 177,473,616 |
| Medical Health Inc. Creative 10% owner | Jun 30, 2019 | Other | +10,000,000 | $0.01 | $100.00K | 77,473,616 |
| Timothy Warbington President & CEO, Director, 10% owner | Jun 30, 2019 | Other | +10,000,000 | $0.01 | $100.00K | 77,473,616 |
| Medical Health Inc. Creative 10% owner | Oct 17, 2018 | Conversion | +4,444,444 | $0.02 | $88.89K | 72,955,661 |
| Timothy Warbington President & CEO, Director, 10% owner | Oct 17, 2018 | Conversion | +4,444,444 | $0.02 | $88.89K | 72,955,661 |
| Timothy Warbington President & CEO, Director, 10% owner | Apr 11, 2018 | Conversion | +9,855,290 | $0.01 | $98.55K | 68,511,217 |
| Medical Health Inc. Creative 10% owner | Apr 11, 2018 | Conversion | +9,855,290 | $0.01 | $98.55K | 68,511,217 |
| Timothy Warbington CEO & President, Director, 10% owner | Aug 29, 2017 | Sale | −5,000 | $0.20 | $1.00K | 58,655,927 |
| Medical Health Inc. Creative 10% owner | Aug 29, 2017 | Sale | −5,000 | $0.20 | $1.00K | 58,655,927 |
| Timothy Warbington President & CEO, Director, 10% owner | Jun 5, 2017 | Sale | −2,800 | $0.30 | $840 | 58,605,927 |
| Timothy Warbington President & CEO, Director, 10% owner | Jun 5, 2017 | Sale | −2,500 | $0.31 | $775 | 58,608,727 |
| Medical Health Inc. Creative 10% owner | Jun 5, 2017 | Sale | −2,500 | $0.31 | $775 | 58,608,727 |
| Medical Health Inc. Creative 10% owner | Jun 5, 2017 | Sale | −2,800 | $0.30 | $840 | 58,605,927 |
| Timothy Warbington President & CEO, Director, 10% owner | Jun 2, 2017 | Sale | −2,200 | $0.42 | $924 | 58,611,227 |
| Timothy Warbington President & CEO, Director, 10% owner | Jun 2, 2017 | Sale | −3,500 | $0.40 | $1.40K | 58,613,427 |
| Medical Health Inc. Creative 10% owner | Jun 2, 2017 | Sale | −2,200 | $0.42 | $924 | 58,611,227 |
| Medical Health Inc. Creative 10% owner | Jun 2, 2017 | Sale | −3,500 | $0.40 | $1.40K | 58,613,427 |
| Timothy Warbington President & CEO, Director, 10% owner | May 18, 2017 | Sale | −1,400 | $0.45 | $630 | 58,616,927 |
| Medical Health Inc. Creative 10% owner | May 18, 2017 | Sale | −1,400 | $0.45 | $630 | 58,616,927 |
| Medical Health Inc. Creative 10% owner | Dec 31, 2016 | Sale | −2,935,609 | $0.10 | $293.56K | 58,618,267 |
| Timothy Warbington President & CEO, Director, 10% owner | Dec 31, 2016 | Sale | −2,935,609 | $0.10 | $293.56K | 58,618,267 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.